top of page

Developing Next Generation Probiotics  and Phage Therapies for Human Health.

dbl_newlogoname.png

Our Mission

We are revolutionizing gastrointestinal medicine by developing next-generation therapies that combine the precision of bacteriophages with the resilience of beneficial bacteria. Our mission is to create effective, accessible treatments for antibiotic-resistant infections while reducing healthcare costs and improving patient outcomes. Through innovative engineering of probiotics and targeted phage delivery systems, we're building alternatives to traditional antibiotics that work in harmony with the human microbiome rather than disrupting it. We believe the future of infection treatment lies in nature's own tools - viruses that target specific pathogens and beneficial bacteria that restore gut health.

Contact us
Follow us  on Twitter.

  • Twitter

Thanks for submitting!

bottom of page